CLINICAL STUDY: RISK FACTORS
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
N. Norman Chan, MB, MRCPa,
Helen M. Colhoun, MD, MFPHM*,a and
Patrick Vallance, PhD, FRCP
a EURODIAB, Department of Epidemiology and Public HealthUniversity College London, London, United Kingdom
Centre for Clinical Pharmacology, University College London, London, United Kingdom
Manuscript received April 17, 2001;
revised manuscript received August 23, 2001,
accepted September 4, 2001.
* Reprint requests and correspondence: Dr. Helen M. Colhoun, EURODIAB, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, United Kingdom Helen{at}public-health.ucl.ac.uk
OBJECTIVES
We examined to what extent the variation in risk factors for coronary heart disease (CHD) and the Framingham risk score (FRS) explain the variation in vascular reactivity in adults aged 30 to 53 years.
BACKGROUND
The role of risk factors in determining vascular reactivity in the general population has not been quantified.
METHODS
Risk factors for CHD were measured, and the FRS was calculated in 69 healthy volunteers. Lipoprotein particle size was measured using proton-nuclear magnetic resonance spectroscopy. Forearm plethysmography was used to assess blood flow responses to acetylcholine (ACh), bradykinin (BK), glyceryl trinitrate (GTN), noradrenaline and NG-monomethyl-L-arginine (L-NMMA).
RESULTS
Lower ACh and BK responses were associated with a higher body mass index (BMI), a higher total cholesterol to high-density lipoprotein (HDL) cholesterol ratio, lower HDL cholesterol and a cigarette smoking habit (all p < 0.05). Higher low-density lipoprotein (LDL) cholesterol was also associated with a lower BK response (p = 0.001). A decreased GTN response was associated with a higher BMI and total cholesterol to HDL cholesterol ratio (both p < 0.05). A decreased L-NMMA response was associated with a smoking habit (p < 0.001). Lipoprotein particle sizes did not independently predict any vascular response. A high FRS was associated with a reduced response to ACh (p = 0.07), BK (p = 0.003) and L-NMMA (p = 0.003), and the relationship was stronger in women than in men. Altogether, risk factors explained 13%, 9%, 8% and 15% of the response to ACh, BK, GTN and L-NMMA, respectively.
CONCLUSIONS
Lipids, BMI and smoking are important determinants of vascular reactivity. The FRS is predictive of agonist-stimulated, endothelium-dependent vasodilation and basal NO release. However, much of the variation in the vascular responses to these drugs, at this age, remains unexplained.
|
Abbreviations and Acronyms
| | ACh | = acetylcholine | | BK | = bradykinin | | BMI | = body mass index | | CHD | = coronary heart disease | | FRS | = Framingham risk score | | GTN | = glyceryl trinitrate | | HDL | = high-density lipoprotein | | LDL | = low-density lipoprotein | | L-NMMA | = NG-monomethyl-L-arginine | | NO | = nitric oxide | | PNMR | = proton-nuclear magnetic resonance |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. Magne, J. F. Huneau, D. Tsikas, S. Delemasure, L. Rochette, D. Tome, and F. Mariotti
Rapeseed Protein in a High-Fat Mixed Meal Alleviates Postprandial Systemic and Vascular Oxidative Stress and Prevents Vascular Endothelial Dysfunction in Healthy Rats
J. Nutr.,
September 1, 2009;
139(9):
1660 - 1666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Van Linthout, F. Spillmann, M. Lorenz, M. Meloni, F. Jacobs, M. Egorova, V. Stangl, B. De Geest, H.-P. Schultheiss, and C. Tschope
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor
Hypertension,
April 1, 2009;
53(4):
682 - 687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gomaraschi, D. Baldassarre, M. Amato, S. Eligini, P. Conca, C. R. Sirtori, G. Franceschini, and L. Calabresi
Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant
Circulation,
November 6, 2007;
116(19):
2165 - 2172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Melikian, M. T. Kearney, M. R. Thomas, B. De Bruyne, A. M. Shah, and P. A. MacCarthy
A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve
Eur. Heart J.,
September 2, 2007;
28(18):
2188 - 2194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Pena, E. Wiltshire, K. MacKenzie, R. Gent, L. Piotto, C. Hirte, and J. Couper
Vascular Endothelial and Smooth Muscle Function Relates to Body Mass Index and Glucose in Obese and Nonobese Children
J. Clin. Endocrinol. Metab.,
November 1, 2006;
91(11):
4467 - 4471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sari, T. Okan, S. Akar, H. Cece, C. Altay, M. Secil, M. Birlik, F. Onen, and N. Akkoc
Impaired endothelial function in patients with ankylosing spondylitis
Rheumatology,
March 1, 2006;
45(3):
283 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hesse, H. Siedler, S. P. Luntz, B. M. Arendt, R. Goerlich, R. Fricker, M. Heer, and W. E. Haefeli
Modulation of endothelial and smooth muscle function by bed rest and hypoenergetic, low-fat nutrition
J Appl Physiol,
December 1, 2005;
99(6):
2196 - 2203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nair, R. K Oka, L. D Waring, E. M Umoh, C B. Taylor, and J. P Cooke
Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors
Vascular Medicine,
November 1, 2005;
10(4):
275 - 283.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lind, N. Fors, J. Hall, K. Marttala, and A. Stenborg
A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
Arterioscler Thromb Vasc Biol,
November 1, 2005;
25(11):
2368 - 2375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L C Jones and A D Hingorani
Genetic regulation of endothelial function
Heart,
October 1, 2005;
91(10):
1275 - 1277.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Smeeth, S. L. Thomas, A. J. Hall, R. Hubbard, P. Farrington, and P. Vallance
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
N. Engl. J. Med.,
December 16, 2004;
351(25):
2611 - 2618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, H. Takashima, N. Ohira, Y. Tarutani, Y. Yasuda, T. Yamane, S. Matsuo, and M. Horie
Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin
J. Am. Coll. Cardiol.,
July 21, 2004;
44(2):
451 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Thomas, P. Chook, M. Qiao, X. S. Huang, H. C. Leong, D. S. Celermajer, and K. S. Woo
Deleterious Impact of "High Normal" Glucose Levels and Other Metabolic Syndrome Components on Arterial Endothelial Function and Intima-Media Thickness in Apparently Healthy Chinese Subjects: The CATHAY Study
Arterioscler Thromb Vasc Biol,
April 1, 2004;
24(4):
739 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Calabresi, M. Gomaraschi, and G. Franceschini
Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside
Arterioscler Thromb Vasc Biol,
October 1, 2003;
23(10):
1724 - 1731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kimura, Y. Higashi, K. Hara, K. Noma, S. Sasaki, K. Nakagawa, C. Goto, T. Oshima, M. Yoshizumi, and K. Chayama
PDE5 Inhibitor Sildenafil Citrate Augments Endothelium-Dependent Vasodilation in Smokers
Hypertension,
May 1, 2003;
41(5):
1106 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|